Effect of Doxepin and Nortriptyline on Irritable Bowel Syndrome
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The objective of this randomized triple blind controlled trial is to compare the effects of Doxepin and Nortriptyline on diarrhea predominant irritable bowel syndrome. In this stuy, 75 patients with IBS are randomly assigned to receive Doxepin , Nortriptyline or placebo, a tablet per day, orally, for two months. Abdominal pain, mucus in the stool, incomplete evacuation, and bloating are measured and compared between groups at the baseline and one and two month after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2010
CompletedFirst Posted
Study publicly available on registry
December 31, 2010
CompletedDecember 31, 2010
December 1, 2010
December 30, 2010
December 30, 2010
Conditions
Study Arms (3)
doxepin
ACTIVE COMPARATORnortriptyline
ACTIVE COMPARATORplacebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Presence of diarrhea predominant irritable bowel syndrome according to ROME criteria
You may not qualify if:
- Gastrointestinal bleeding
- More than 5% weight loss in the last 6 months
- Presence of any finding in favor of organic disorders in the lab tests or organic disorder in colonoscopy of high risk patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Qom University of Medical Scienceslead
- Young Researchers Clubcollaborator
Study Sites (1)
Gastrointestinal Research center,Beheshti Hospital
Qom, Qom Province, 1677859642, Iran
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Purpose
- TREATMENT
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 30, 2010
First Posted
December 31, 2010
Last Updated
December 31, 2010
Record last verified: 2010-12